Related Experiment Video
Updated: Jan 23, 2026

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
On the behavioral economics of medication choice: A research story
David P Jarmolowicz1, Derek D Reed1, Amanda S Bruce2
1University of Kansas, Department of Applied Behavior Science, United States; University of Kansas, Cofrin Logan Center for Addiction Research and Treatment, United States.
Abstract:
Behavioral economics has been consistently useful in describing a wide range of clinical phenomena, particularly in reference to behavioral excesses such as substance abuse, problematic gambling and obesity/overeating. Given an opportunity to explore these processes as they relate to treatment adherence in patients with multiple sclerosis (MS), our central thesis was that behavioral economic tools/processes that have been helpful in other areas of application (e.g., substance abuse, obesity) could be leveraged to help understand treatment non-adherence and hopefully lead to efforts to combat it. The current paper tells a story of how an interdisciplinary set of researchers came to combine their separate expertise in MS and behavioral economics to yield novel insights into the failures of treatment adherence often experienced in this clinical population.
Related Concept Videos
Mate Choice
Inhaled Medications
What is Behavior?
Personal Choice and Fate Attributions
Factors Affecting α-Alkylation of Ketones: Choice of Base
The reaction involving bases like EtO− whose conjugate acid EtOH (pKa = 15.9) is stronger than the ketone (pKa = 19.2) results in an equilibrium mixture with higher ketone concentration. As a consequence,...
Endocarditis III: Medical Management

